Skip to main content
. 2018 Oct 25;3(2):180–185. doi: 10.1002/bjs5.50116

Table 1.

Baseline characteristics of patients in SECA‐1 trial

No. of patients* (n = 23)
Age (years) 54·7 (44·5–64·7)
Sex ratio (F : M) 10 : 13
Tumour site
Colon 13
Rectum 10
Timing of metastasis
Synchronous 19
Metachronous 4
Liver resection before LT 4
Chemotherapy before LT (no. of lines)
1 10
2 9
3 4
> 10 liver metastases 8
Largest lesion > 5 cm 10
CEA > 5 μg/l 14
*

Unless indicated otherwise.

Values are median (range). LT, liver transplantation; CEA, carcinoembryonic antigen.